Allspring Global Investments Holdings LLC Has $312,000 Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Allspring Global Investments Holdings LLC raised its stake in Select Medical Holdings Co. (NYSE:SEM) by 172.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,579 shares of the health services provider’s stock after purchasing an additional 10,491 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Select Medical were worth $312,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in SEM. Point72 Asset Management L.P. boosted its stake in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after acquiring an additional 1,216,263 shares during the period. Empowered Funds LLC acquired a new stake in shares of Select Medical in the fourth quarter valued at approximately $5,903,000. Loomis Sayles & Co. L P acquired a new stake in shares of Select Medical during the 3rd quarter worth $9,710,000. LMR Partners LLP bought a new position in Select Medical in the 3rd quarter valued at about $6,139,000. Finally, Barclays PLC raised its position in Select Medical by 396.0% during the third quarter. Barclays PLC now owns 192,357 shares of the health services provider’s stock valued at $6,707,000 after purchasing an additional 153,576 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 19.14% of the stock is owned by company insiders.

Select Medical Stock Performance

Shares of SEM stock opened at $19.16 on Wednesday. Select Medical Holdings Co. has a one year low of $16.20 and a one year high of $40.98. The firm has a 50-day moving average of $19.07 and a 200-day moving average of $27.81. The company has a market cap of $2.48 billion, a P/E ratio of 11.61, a P/E/G ratio of 0.64 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Equities research analysts forecast that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd will be given a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.31%. The ex-dividend date is Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is currently 30.30%.

Analyst Upgrades and Downgrades

SEM has been the topic of several research reports. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, February 21st. Royal Bank of Canada reduced their price objective on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday. UBS Group cut their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Monday. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Select Medical has an average rating of “Moderate Buy” and an average target price of $27.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.